1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZYDUS LIFESCIENCES LTD.
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE | BSE: 532321

Zydus Lifesciences Ltd. Live Share Price Today, Share Analysis and Chart

Mid-range Performer
about

Founded in 1952, Zydus Lifesciences (formerly Cadila Healthcare) is a global pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of healthcare therapies. Its portfolio includes generics, branded generics, biosim...

Read More
979.60 6.65 (0.68%)
26.03% Fall from 52W High
981.3K
NSE+BSE Volume

NSE 11 Jul, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Dividend
Zydus Lifesciences Ltd. has an upcoming dividend of ₹11.00 per share due on 25 Jul 2025 See details
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
65.0 / 100
Valuation Score
Mid Valuation
45.7 / 100
Momentum Score
Technically Neutral
48.6 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
967
1Yr Price target downside is -1%
30 analysts

20

S

1

W

3

O

3

T

SWOT Analysis

Zydus Lifesciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
Is Cadila Healthcare Ltd. worth buying?
851 Votes:
Buy 82.02%
Sell 9.87%
Hold 8.11%
BUY
SELL
HOLD